Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BOLD stock hub

Boundless Bio, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOLDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

32.3M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BOLD

In the news

Latest news · BOLD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-50.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-23.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOLD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

USD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001782303
Company name	Boundless Bio, Inc.
Country	United States
Country code	US
Cusip	10170A100
Employees	28
Employees Change	-36%
Employees Change Percent	-56.25
Enterprise value	$-12.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-03-28
Isin	US10170A1007
Last refreshed	2026-05-10
Market cap	$32.3M
Market cap category	Nano-Cap
Price	$1.44
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	BOLD
Website	https://boundlessbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-173.46%
FCF yield	-147.45%
P/B ratio	0.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-56M
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Profit Per Employee	$-2M
ROA	-22.83
ROCE	-46.19
ROE	-50.22
ROIC	-23.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-5.89%
EPS Growth Quarters	8
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$141M
Cash	$92.8M
Current Assets	$94.6M
Current Liabilities	$9.6M
Debt	$48.3M
Debt Equity	$0.56
Equity	$86.4M
Liabilities	$54.6M
Long Term Assets	$46.4M
Long Term Liabilities	$45M
Net Cash	$44.6M
Net Cash By Market Cap	$138
Net Cash Growth	-50.31%
Net Debt Equity	$-0.52
Tangible Book Value	$86.4M
Tangible Book Value Per Share	$3.86
WACC	3.8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.87
Net Working Capital	$-4.5M
Quick ratio	9.69
Working Capital	$85M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.64%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-5.88%
200-day SMA	1.23
50-day SMA	1.29
50-day SMA vs 200-day SMA	50over200
All Time High	15.24
All Time High Change	-90.55%
All Time High Date	2024-03-28
All Time Low	0.96
All Time Low Change	49.81%
All Time Low Date	2026-02-05
ATR	0.09
Beta	0.95
Beta1y	2.01
Beta2y	1.95
Ch YTD	20
High	1.56
High52	1.73
High52 Date	2025-05-19
High52ch	-16.52%
Low	1.41
Low52	0.96
Low52 Date	2026-02-05
Low52ch	49.81%
Ma50ch	11.63%
Premarket Change Percent	1.54
Premarket Price	$1.55
Premarket Volume	3,365
Price vs 200-day SMA	17.55%
RSI	50.61
RSI Monthly	11.65
RSI Weekly	56.41
Sharpe ratio	0.11x
Sortino ratio	0.29
Total Return	-0.64%
Tr YTD	20
Tr1m	26.32%
Tr1w	-8.28%
Tr3m	24.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	2
Analyst Price Target Top	$3.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.55
Operating Income	$-60.7M
Price target	$4
Price Target Change	$178
Price Target Change Top	$143

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,300,534%
Float Percent	68.25%
Shares Insiders	1.72%
Shares Institutions	38.38%
Shares Out	22,417,270
Shares Qo Q	0.86%
Shares Yo Y	0.64%
Short Float	0.95%
Short Ratio	0.36
Short Shares	0.65

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-53.3M
Average Volume	464,029.55x
Bv Per Share	3.86
CAPEX	$-495,000
Ch1m	26.32
Ch1w	-8.28
Ch1y	-5.88
Ch3m	24.14
Ch6m	17.07
Change	-5.88%
Change From Open	-5.26
Close	1.53
Days Gap	-0.65
Depreciation Amortization	1,218,000
Dollar Volume	575,631.4
Earnings Date	2026-05-08
Earnings Time	bmo
EBIT	$-60.7M
EBITDA	$-59.5M
EPS	$-2.5
F Score	1
FCF	$-47.6M
FCF EV Yield	387.66x
FCF Per Share	$-2.12
Financing CF	141,000
Fiscal Year End	December
Founded	2,018
Investing CF	49,328,000
Ipr	-91
Iprfo	-89.89
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-09
Ma150	1.25
Ma150ch	15.48%
Ma20	1.52
Ma20ch	-5.33%
Net CF	2,366,000
Next Earnings Date	2026-08-04
Open	1.52
Optionable	No
Position In Range	20.69
Post Close	1.44
Postmarket Change Percent	4.17
Postmarket Price	$1.5
Ppne	45,771,000
Pre Close	1.53
Price Date	2026-05-08
Ptbv Ratio	0.37
Relative Volume	0.86x
Share Based Comp	5,699,000
Tr6m	17.07%
Us State	California
Volume	399,744

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOLD pay a dividend?

Capital-return profile for this ticker.

Performance

BOLD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOLD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+38.4%

Float: +68.3% of shares outstanding

Insider ownership

+1.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BOLD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.6

Neutral momentum band

Price vs 200-day MA

+17.6%

50/200-day relationship not available

Beta (5Y)

0.95

Moves roughly with the market

Sharpe ratio

0.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOLD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BOLD stock rating?

Boundless Bio, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BOLD analysis?

The full report lives at /stocks/BOLD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BOLD?

The latest report frames BOLD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BOLD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.